InvestorsHub Logo

DewDiligence

04/08/15 11:33 AM

#189701 RE: oldberkeley #189696

There's a correlation, not sure why.

Less money being spent on staffers means more money available for raises and bonuses for top management. The correlation may be that simple.

caravon

04/08/15 11:26 PM

#189754 RE: oldberkeley #189696

It is of interest that ARQL's CEO earns almost as much as CEOs of ENTA and CLVS combined.

As I indicated some time ago, IMHO, good many biotech CEOs are exclusively in a business of self enrichment.